AngioDynamics Inc
NASDAQ:ANGO
AngioDynamics Inc
Revenue
AngioDynamics Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AngioDynamics Inc
NASDAQ:ANGO
|
Revenue
$324m
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-1%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
AngioDynamics Inc
Revenue Breakdown
Breakdown by Geography
AngioDynamics Inc
Total Revenue:
338.8m
USD
|
United States:
282.7m
USD
|
International:
56m
USD
|
Breakdown by Segments
AngioDynamics Inc
Total Revenue:
338.8m
USD
|
Med Device:
242.1m
USD
|
Med Tech:
96.7m
USD
|
See Also
What is AngioDynamics Inc's Revenue?
Revenue
324m
USD
Based on the financial report for Feb 29, 2024, AngioDynamics Inc's Revenue amounts to 324m USD.
What is AngioDynamics Inc's Revenue growth rate?
Revenue CAGR 10Y
-1%
Over the last year, the Revenue growth was -3%. The average annual Revenue growth rates for AngioDynamics Inc have been 6% over the past three years , 10% over the past five years , and -1% over the past ten years .